QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
NASDAQ:APDN

Applied DNA Sciences - APDN Stock Forecast, Price & News

$1.45
-0.07 (-4.61%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.35
▼
$1.50
50-Day Range
$0.68
▼
$5.83
52-Week Range
$0.62
▼
$7.35
Volume
942,531 shs
Average Volume
2.62 million shs
Market Capitalization
$17.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Applied DNA Sciences MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
382.8% Upside
$7.00 Price Target
Short Interest
Healthy
6.64% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.43) to ($0.83) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Industrial Products Sector

165th out of 178 stocks

Miscellaneous Business Services Industry

6th out of 6 stocks

See Top Rated MarketRank™ Stocks Here
APDN stock logo

About Applied DNA Sciences (NASDAQ:APDN) Stock

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Stock News Headlines

September 30, 2022 | finance.yahoo.com
Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
September 28, 2022 | seekingalpha.com
APDN Applied DNA Sciences, Inc.
September 26, 2022 | americanbankingnews.com
Applied DNA Sciences (NASDAQ:APDN) Upgraded to Hold by StockNews.com
September 24, 2022 | finance.yahoo.com
Applied DNA Sciences, Inc. (APDN)
September 8, 2022 | finance.yahoo.com
Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health Applications
September 7, 2022 | finance.yahoo.com
Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
September 6, 2022 | finance.yahoo.com
Applied DNA Launches Monkeypox Testing Service
August 19, 2022 | finance.yahoo.com
Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health
August 17, 2022 | finance.yahoo.com
Analyst Forecasts For Applied DNA Sciences, Inc. (NASDAQ:APDN) Are Surging Higher
August 12, 2022 | seekingalpha.com
Applied DNA Sciences stock falls ~14% after massive runup last week, Q3 results
August 11, 2022 | finance.yahoo.com
Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
August 11, 2022 | finance.yahoo.com
Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates
August 10, 2022 | finance.yahoo.com
Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)
August 9, 2022 | finance.yahoo.com
Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise
August 9, 2022 | finance.yahoo.com
Applied DNA Awarded Extension of Health Services Contract with The City University of New York
August 8, 2022 | finance.yahoo.com
Applied DNA Announces Closing of Upsized $12 Million Public Offering
August 8, 2022 | finance.yahoo.com
Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates
August 5, 2022 | nasdaq.com
Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?
August 3, 2022 | msn.com
Short Volatility Alert: Applied DNA Sciences, Inc.
August 3, 2022 | benzinga.com
Looking At Applied DNA Sciences's Recent Whale Trades
August 3, 2022 | finance.yahoo.com
Will Applied DNA Sciences (NASDAQ:APDN) Spend Its Cash Wisely?
August 3, 2022 | finance.yahoo.com
Applied DNA stock soars more than 80% active trading, after quadrupling in the previous session
August 2, 2022 | finance.yahoo.com
Applied DNA Sciences Shares Triples After Monkeypox Diagnostic Test Update
August 2, 2022 | finance.yahoo.com
Applied DNA Initiates Analytical Validation of PCR-based Diagnostic Test Specific to Monkeypox Virus
July 25, 2022 | finance.yahoo.com
Applied DNA Biotherapeutics Subsidiary LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Development
See More Headlines
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Company Calendar

Last Earnings
8/11/2022
Today
10/05/2022
Next Earnings (Estimated)
12/08/2022
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Miscellaneous business services
Sub-Industry
N/A
Sector
Industrial Products
Current Symbol
NASDAQ:APDN
CUSIP
N/A
CIK
744452
Web
www.adnas.com
Phone
(631) 240-8800
Fax
631-240-8900
Employees
78
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+382.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,290,000.00
Net Margins
-68.79%
Pretax Margin
-68.79%
Return on Equity
-158.37%
Return on Assets
-104.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.16
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$9.03 million
Price / Sales
1.92
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.48 per share
Price / Book
0.98

Miscellaneous

Outstanding Shares
11,983,000
Free Float
11,220,000
Market Cap
$17.38 million
Optionable
Optionable
Beta
0.45

Key Executives

  • Dr. James A. Hayward Ph.D. (Age 68)
    Sc.D., Chairman, Pres & CEO
    Comp: $984.84k
  • Ms. Beth M. Jantzen CPA (Age 46)
    CPA, Chief Financial Officer
    Comp: $278.85k
  • Ms. Judith Murrah (Age 64)
    COO & Sec.
    Comp: $314.42k
  • Mr. Sanjay M. Hurry
    Exec. Director of Investor Relations & Corp. Communications
  • Mr. Clay Shorrock Esq. (Age 37)
    J.D., Chief Legal Officer & Exec. Director of Bus. Devel.
  • Mr. John Shearman
    Exec. Director of Marketing & Cannabis Bus.
  • Mr. Tony Benson
    Managing Director of EMEA
  • Ms. Janice Meraglia
    VP, Gov. & Military Programs
  • Ms. MeiLin Wan
    VP of Textile Sales
  • Dr. Stephen Hughes
    Director of DNA Programs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













APDN Stock - Frequently Asked Questions

What is Applied DNA Sciences' stock price forecast for 2022?

0 Wall Street analysts have issued 1 year price targets for Applied DNA Sciences' shares. Their APDN share price forecasts range from $6.00 to $8.00. On average, they expect the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 389.5% from the stock's current price.
View analysts price targets for APDN or view top-rated stocks among Wall Street analysts.

How have APDN shares performed in 2022?

Applied DNA Sciences' stock was trading at $4.02 at the start of the year. Since then, APDN shares have decreased by 64.4% and is now trading at $1.43.
View the best growth stocks for 2022 here.

When is Applied DNA Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 8th 2022.
View our APDN earnings forecast.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) released its quarterly earnings results on Thursday, August, 11th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.32) by $0.19. Applied DNA Sciences had a negative trailing twelve-month return on equity of 158.37% and a negative net margin of 68.79%.

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

How do I buy shares of Applied DNA Sciences?

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $1.43.

How much money does Applied DNA Sciences make?

Applied DNA Sciences (NASDAQ:APDN) has a market capitalization of $17.13 million and generates $9.03 million in revenue each year. The technology company earns $-14,290,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The official website for the company is www.adnas.com. The technology company can be reached via phone at (631) 240-8800, via email at investor@adnas.com, or via fax at 631-240-8900.

This page (NASDAQ:APDN) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.